What is Healthcare Mittelhessen?

Education, research, economy: The intensive networking in the health sector and medicine makes the location Central Hessen special throughout Germany. We want to link this networking in the healthcare sector even more closely with the Mittelhessen brand in order to convince new investors, specialists and cooperation partners of the successful medical industry location of Mittelhessen.

The University of Marburg has the largest department for Pharmacy in Germany.

With turnover of four billion euros and export ratio of over 90 percent, Hessen is one of the supporting pillars of the German medical technology industry.

Around 150 Central Hessian companies are specialized in the field of pharma and medical technology.

With around 9,600 employees the Universitätsklinikum Gießen/Marburg (UKGM) is the largest medium-sized Hessian company and the third largest university hospital in Germany.

Latest Storys

standortbild-csl-behring-marburg
Marburg-based pharmaceutical company CSL Behring is conducting intensive research on a suitable active substance against Covid-19 with the use of donated blood plasma. A globally active "Plasma Alliance" established for this purpose supports the company's goals.
hcm_beitrag_Kampf_gegen_COVID_19
The fight against SARS-CoV-2 can be conducted on different levels. Alcedis is currently participating in three clinical studies on coronavirus infection.
Good medicine needs secure financing: The medService of Volksbank Mittelhessen offers doctors, pharmacies and clinics tailor-made financing for investments, devices and office equipment.
Giessen dermatologist and professor Dr. Peter Mayser has succeeded in developing a natural anti-dandruff agent in collaboration with Symrise AG, which is being marketed under the name Crinipan® PMC green.
Courses of study with a focus on healthcare are growing enormously at the Technical University of Middle Hessen (THM) in Giessen. University President Prof. Matthias Willems provide insights into exciting developments in the field of digitization.
A research team from the University of Marburg has successfully used the cancer drug ruxolitinib to treat a 65-year-old female patient suffering from acute lung failure after coronavirus infection.

AI in medicine: Marburg leading the way

04.03.2020

A pioneer in international AI research, Prof. Dr. Martin Hirsch takes the helm at Philipps University and the University Hospital in Marburg. With this newly created professorship, Marburg leads the way as a model region for AI-supported medicine.
Learn more ...

A world first in Lich: Asklepios Hospital implants an 'intestinal pacemaker'

19.02.2020

It's a milestone in treating fecal incontinence: For the first time, an MRI-capable intestinal pacemaker was implanted in a patient at the Licher branch of Asklepios Hospitals. This breakthrough is great news for patients who have to undergo intestinal MRIs regularly.
Learn more ...

Implementation of the EU Medical Device Regulation well underway

12.02.2020

Expected bottlenecks don't manifest: More and more medical device manufacturers are "MDR-ready". For everyone else, MedTech Europe has now published concrete recommendations.
Learn more ...



Banner HCM